Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...

CStone, the drug’s developer, previously announced similar deals with various pharmaceutical companies to expand sugemalimab ...

Health In Tech announced new partnerships that it says will allow it to introduce a new self-funded health plan. 1 The ...

The government agency says X no longer suits its communication needs.

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.

Veeva’s vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can ...

Campaign encourages the use of low-dose aspirin to help reduce the risk of preeclampsia and the complications that come with ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

The trial, developed in collaboration with Novotech, will specifically target dietary and alcohol-induced overindulgence.

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...

Trial findings show long-term recurrence-free survival in patients with low-grade upper tract urothelial cancer treated with ...